非蘇拉贊
![]() | |
臨床資料 | |
---|---|
商品名 | Fexuclue |
其他名稱 | Abeprazan; DWP14012; DWP-14012 |
法律規範狀態 | |
法律規範 |
|
識別資訊 | |
| |
CAS號 | 1902954-60-2 |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
化學資訊 | |
化學式 | C19H17F3N2O3S |
摩爾質量 | 410.41 g·mol−1 |
3D模型(JSmol) | |
| |
|
非蘇拉贊(英語:Fexuprazan,商品名Fexuclue,分子式:C19H17F3N2O3S)是一種治療胃食道逆流病的藥物,[1]它是一種鉀離子競爭性酸阻滯劑。[2]
參考文獻
- ^ Ramani, Azaan; Merchant, Alisha; Cash, Brooks D. Review of the clinical development of fexuprazan for gastroesophageal reflux–related disease. European Journal of Clinical Pharmacology. 2023, 79 (8): 1023–1029. PMID 37344679. S2CID 259222741. doi:10.1007/s00228-023-03521-4.
- ^ Kim, Gwang Ha; Choi, Myung-Gyu; Kim, Jin Il; Lee, Soo Teik; Chun, Hoon Jai; Lee, Kook Lae; Choi, Suk Chei; Jang, Jae-Young; Lee, Yong Chan; Kim, Jae Gyu; Kim, Ki Bae; Shim, Ki-Nam; Sohn, Chong Il; Kim, Sung Kook; Kim, Sang Gyun; Jang, Jin Seok; Kim, Nayoung; Jung, Hwoon-Yong; Park, Hyojin; Huh, Kyu Chan; Lee, Kwang Jae; Hong, Su Jin; Baek, Song; Han, Jin Joo; Lee, Oh Young. Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis. Gut and Liver. 2023, 17 (6): 884–893. PMC 10651377
. PMID 36789577. doi:10.5009/gnl220457.
- ^ 펙수클루정40밀리그램(펙수프라잔염산염). nedrug.mfds.go.kr.
- ^ Daewoong Pharma's GER drug gets product OK from Mexico. Korea Economic Daily. October 19, 2023 [2023-11-30]. (原始內容存檔於2023-11-28).